Search results for: “FDA Approval”
-
Agronomics’ Onego Bio raises €27 million in Series A financing led by NordicNinja VC
•
LONDON: Agronomics (LSE: ANIC) portfolio company Onego Bio Ltd has successfully raised €27 million in its Series A…
-
Autolus Therapeutics reports financial growth amidst rising R&D costs
•
LONDON: In a company announcement, Autolus Therapeutics plc (Nasdaq: AUTL), a trailblazer in programmed T cell therapies, has…
-
Philips reports strong sales and profit growth in 2023
•
AMSTERDAM: Philips, a global leader in health technology, announced its 2023 financial results, showing a 7% increase in…
-
Abivax outlines 2024 goals for obefazimod, a novel oral drug for inflammatory diseases
•
Abivax SA, a French biotech company listed on Euronext Paris and Nasdaq, is developing a new class of…
-
Inspiration Healthcare acquires Airon Corporation for $2.5 million
•
LONDON, UK: Inspiration Healthcare (AIM: IHC) announced the acquisition of Airon Corporation, a specialist respiratory device company based…
-
Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion
•
Bristol Myers Squibb (BMY) announced today that it has agreed to acquire Karuna Therapeutics (KRTX), a biopharmaceutical company…
-
MaxCyte names Maher Masoud new CEO as Doug Doerfler retires after 24 years
•
LONDON, UK: MaxCyte, Inc., a leading cell-engineering company, announced today that Maher Masoud will take over as President…
-
Smith+Nephew to acquire CartiHeal, developer of Agili-C, for upto $330 million
•
LONDON, UK: Smith+Nephew, the global medical technology company, has entered into a definitive agreement to acquire CartiHeal, developer…
-
AstraZeneca’s Truqap approved in US for advanced breast cancer
•
LONDON: AstraZeneca announced that its drug Truqap (capivasertib) has received approval from the US Food and Drug Administration…
-
Telix Pharmaceuticals to acquire QSAM Biosciences and its bone cancer therapy
•
MELBOURNE, AUSTRALIA: Telix Pharmaceuticals Limited, an Australian company that develops radiopharmaceuticals for cancer diagnosis and treatment, has announced…
-
Avingtrans reports strong results and order book, proposes acquisition of Adaptix
•
LONDON, UK: Avingtrans plc (AIM: AVG), the engineering technology group, has announced a trading update for the financial…
-
Telix Pharmaceuticals to boost AI capabilities with acquisition of Dedicaid GmbH
•
MELBOURNE, AUSTRALIA: Melbourne-based Telix Pharmaceuticals Limited (ASX: TLX) has signed an agreement to acquire Dedicaid GmbH, a Vienna-based…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.